INTERNATIONAL PATENT: ASCIDIAN THERAPEUTICS, INC. FILES APPLICATION FOR "MECP2 TRANS-SPLICING MOLECULES"

GENEVA, May 28 -- ASCIDIAN THERAPEUTICS, INC. (80 Guest StreetBoston, Massachusetts 02135) filed a patent application (PCT/US2024/055758) for "MECP2 TRANS-SPLICING MOLECULES" on Nov 13, 2024. With publication no. WO/2025/106562, the details related to the patent application was published on May 22, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CLEMENS, Adam (c/o Ascidian Therapeutics, Inc., 80 Guest StreetBoston, Massachusetts 02135), GRAY, Jesse (c/o Ascidian Therapeutics, Inc., 80 Guest StreetBoston, Massachusetts 02135), BURKHART, Kirk (c/o Ascidian Therapeutics, Inc., 80 Guest StreetBo...